Publication | Open Access

Design of new potent and selective secretory phospholipase A2 inhibitors. 6-Synthesis, structure–activity relationships and molecular modelling of 1-substituted-4-[4,5-dihydro-1,2,4-(4H)-oxadiazol-5-one-3-yl(methyl)]-functionalized aryl piperazin/one/dione derivatives

Molecular PharmacologyMedicinal ChemistryBiochemistryPiperazin/one/dione DerivativesMedicineNatural SciencesRational Drug DesignMechanism Of ActionPharmacological AgentPharmacologyMolecular ModelingPharmaceutical ChemistryNew PotentDrug Discovery